1. Project
  2. ReverseTheAdvantage
  3. Organisations

Reversing the advantage of cancers with Hypoxia and Homologous Recombination Defect (HRD) by using a pan-cancer, composite, lesions-specific biomarker

Full project page

Organisations map overview


Powered by Chris Decubber BV